A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
T Kwok, J Lee, CB Law, PC Pan, CY Yung, KC Choi… - Clinical nutrition, 2011 - Elsevier
INTRODUCTION: Whether homocysteine lowering by B vitamins can reduce cognitive
decline in Alzheimer disease and vascular dementia patients is unclear. METHODS AND …
decline in Alzheimer disease and vascular dementia patients is unclear. METHODS AND …
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
T Kwok, J Lee, CB Law, PC Pan… - Clinical …, 2011 - clinicalnutritionjournal.com
Introduction Whether homocysteine lowering by B vitamins can reduce cognitive decline in
Alzheimer disease and vascular dementia patients is unclear. Methods and materials 140 …
Alzheimer disease and vascular dementia patients is unclear. Methods and materials 140 …
[PDF][PDF] A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented peopleq
T Kwok, J Lee, CB Law, PC Panc, CY Yung… - Clinical …, 2011 - academia.edu
Alzheimer disease (AD) and vascular dementia are associated with elevated plasma total
homocysteine (tHCY). For example, plasma tHCY is elevated in patients with AD, 1 stroke …
homocysteine (tHCY). For example, plasma tHCY is elevated in patients with AD, 1 stroke …
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
T Kwok, J Lee, CB Law, PC Pan, CY Yung, KC Choi… - 2011 - cabidigitallibrary.org
Introduction: Whether homocysteine lowering by B vitamins can reduce cognitive decline in
Alzheimer disease and vascular dementia patients is unclear. Methods and materials: 140 …
Alzheimer disease and vascular dementia patients is unclear. Methods and materials: 140 …
[引用][C] A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
T KWOK, J LEE, CB LAW, PC PAN… - Clinical nutrition …, 2011 - pascal-francis.inist.fr
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline
in older demented people CNRS Inist Pascal-Francis CNRS Pascal and Francis …
in older demented people CNRS Inist Pascal-Francis CNRS Pascal and Francis …
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
T Kwok, J Lee, CB Law, PC Pan, CY Yung, KC Choi… - Clinical Nutrition, 2011 - infona.pl
Whether homocysteine lowering by B vitamins can reduce cognitive decline in Alzheimer
disease and vascular dementia patients is unclear. 140 subjects with mild to moderate …
disease and vascular dementia patients is unclear. 140 subjects with mild to moderate …
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
T Kwok, J Lee, CB Law, PC Pan, CY Yung… - Clinical Nutrition …, 2011 - europepmc.org
Results Trial groups were well matched in baseline characteristics. The average plasma
tHCY concentration of subjects was 14.1±3.8 μmol/L. 80% of subjects completed the trial …
tHCY concentration of subjects was 14.1±3.8 μmol/L. 80% of subjects completed the trial …
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
T Kwok, J Lee, CB Law, PC Pan, CY Yung, KC Choi… - 2011 - pubmed.ncbi.nlm.nih.gov
Introduction Whether homocysteine lowering by B vitamins can reduce cognitive decline in
Alzheimer disease and vascular dementia patients is unclear. Methods and materials 140 …
Alzheimer disease and vascular dementia patients is unclear. Methods and materials 140 …
[PDF][PDF] A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented peopleq
T Kwok, J Lee, CB Law, PC Pan, CY Yung… - Clinical …, 2011 - academia.edu
Alzheimer disease (AD) and vascular dementia are associated with elevated plasma total
homocysteine (tHCY). For example, plasma tHCY is elevated in patients with AD, 1 stroke …
homocysteine (tHCY). For example, plasma tHCY is elevated in patients with AD, 1 stroke …